Belpointe Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,374
Closed -$661K 1146
2025
Q4
$661K Buy
8,374
+259
+3% +$20.5K 0.02% 570
2025
Q3
$669K Sell
8,115
-1,279
-14% -$101K 0.03% 536
2025
Q2
$755K Buy
9,394
+516
+6% +$39.8K 0.03% 443
2025
Q1
$713K Buy
8,878
+2,161
+32% +$180K 0.04% 441
2024
Q4
$520K Sell
6,717
-406
-6% -$33.8K 0.03% 496
2024
Q3
$588K Buy
7,123
+1,562
+28% +$117K 0.04% 463
2024
Q2
$390K Sell
5,561
-1,427
-20% -$102K 0.03% 514
2024
Q1
$518K Sell
6,988
-229
-3% -$16K 0.04% 428
2023
Q4
$477K Buy
7,217
+738
+11% +$46.2K 0.04% 382
2023
Q3
$408K Buy
6,479
+961
+17% +$59.9K 0.04% 389
2023
Q2
$312K Sell
5,518
-4,861
-47% -$270K 0.03% 437
2023
Q1
$601K Buy
10,379
+1,108
+12% +$74.8K 0.03% 487
2022
Q4
$671K Sell
9,271
-1,238
-12% -$88.7K 0.04% 417
2022
Q3
$640K Buy
10,509
+1,931
+23% +$123K 0.04% 424
2022
Q2
$539K Sell
8,578
-631
-7% -$41.8K 0.04% 457
2022
Q1
$648K Buy
9,209
+2,977
+48% +$201K 0.04% 449
2021
Q4
$390K Sell
6,232
-11,314
-64% -$710K 0.02% 607
2021
Q3
$1.08M Buy
17,546
+9,864
+128% +$594K 0.07% 289
2021
Q2
$460K Buy
7,682
+1,177
+18% +$74.6K 0.03% 525
2021
Q1
$396K Buy
6,505
+835
+15% +$46.1K 0.03% 502
2020
Q4
$266K Sell
5,670
-12,889
-69% -$559K 0.02% 609
2020
Q3
$690K Buy
18,559
+12,560
+209% +$477K 0.08% 269
2020
Q2
$220K Sell
5,999
-12,101
-67% -$421K 0.03% 499
2020
Q1
$553K Buy
18,100
+52
+0.3% +$2.31K 0.1% 233
2019
Q4
$920K Buy
18,048
+11,935
+195% +$576K 0.12% 194
2019
Q3
$288K Sell
6,113
-7,930
-56% -$378K 0.05% 400
2019
Q2
$698K Buy
14,043
+8,275
+143% +$389K 0.14% 163
2019
Q1
$246K Sell
5,768
-8,825
-60% -$390K 0.05% 273
2018
Q4
$599K Buy
14,593
+9,187
+170% +$394K 0.15% 146
2018
Q3
$253K Buy
+5,406
New +$247K 0.04% 399
2018
Q1
Sell
-7,181
Closed -$363K 429
2017
Q4
$363K Buy
7,181
+1,503
+26% +$79.2K 0.08% 298
2017
Q3
$295K Buy
+5,678
New +$277K 0.07% 320

Other funds holding MET

Belpointe Asset Management's MET Position: Q1 2026 in Review

Belpointe Asset Management sold out of MetLife (MET) in Q1 2026, closing a stake of 8,374 shares — an estimated $661K sold.

Belpointe Asset Management first reported a position in MET in Q3 2017 and held it in 32 quarters. The position peaked at $1.08M in Q3 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Belpointe Asset Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Belpointe Asset Management sold 8,374 MetLife shares in Q1 2026, an estimated $661K.
  • Belpointe Asset Management first reported a position in MetLife in Q3 2017 and held it in 32 quarters.
  • Belpointe Asset Management's MetLife position peaked at $1.08M in Q3 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.